Logo
x

Search

Subscribe Now

Advance

Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease

Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease

  • October 22, 2021
Takeda Amend its Collaboration with Wave Life Sciences to Advance CNS Programs

Takeda Amend its Collaboration with Wave Life Sciences to Advance CNS Programs

  • October 19, 2021
uniQure Provides Positive Recommendation to Advance P- I/II Study of AMT-130 for Huntington Disease

uniQure Provides Positive Recommendation to Advance P- I/II Study of AMT-130 for Huntington Disease

  • May 28, 2021
BMS and PsiOxus Therapeutics Expand their 2016 Immuno-Oncology Collaboration

BMS and PsiOxus Therapeutics Expand their 2016 Immuno-Oncology Collaboration

  • April 8, 2021
Merck Signs a Five-Year Agreement with M2GEN to Advance Cancer Therapies

Merck Signs a Five-Year Agreement with M2GEN to Advance Cancer Therapies

  • March 18, 2021
Veru to Advance VERU-111 in P-III Study for COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome

Veru to Advance VERU-111 in P-III Study for COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome

  • March 2, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.